BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25459180)

  • 1. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
    Bhatt VR; Vose JM
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in the treatment of lymphoma with autologous transplantation.
    Moskowitz AJ; Moskowitz CH
    Oncologist; 2009 Sep; 14(9):921-9. PubMed ID: 19737999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation.
    Eyre TA; Barrington SF; Okosun J; Abamba C; Pearce RM; Lee J; Carpenter B; Crawley CR; Bloor AJC; Gilleece M; Nicholson E; Shah N; Orchard K; Malladi R; Townsend WM
    Haematologica; 2023 Mar; 108(3):785-796. PubMed ID: 35586966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoetic stem cell transplant for patients with refractory T-Cell lymphomas.
    Massoud R; Naim H; Klyuchnikov E; Janson D; Wolschke C; Ayuk F; Kröger N
    Eur J Haematol; 2024 Feb; 112(2):276-285. PubMed ID: 37845834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinatumomab consolidation post-autologous stem cell transplantation in patients with diffuse large B-cell lymphoma.
    Ghobadi A; Foley NC; Cohen J; Rettig MP; Cashen AF; Gehrs L; Christ S; Street E; Wallace N; Ritchey J; Mehta-Shah N; Westervelt P; Fehniger TA; Kahl B; Bartlett NL; DiPersio JF
    Blood Adv; 2024 Feb; 8(3):513-522. PubMed ID: 37871306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.
    Reddy N; Savani BN
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1265-72. PubMed ID: 21621630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
    Okada Y; Kimura F; Kurita N; Takahashi H; Shimazu Y; Mizuno S; Uchida N; Kataoka K; Hiramoto N; Ota S; Kako S; Tsukada N; Kanda Y; Kurahashi S; Doki N; Nishikawa A; Kim SW; Hangaishi A; Kanda J; Fukuda T; Atsuta Y; Kondo E; Kawamura K; Nakasone H
    Cytotherapy; 2023 Nov; 25(11):1212-1219. PubMed ID: 37354150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives.
    Abou Dalle I; Dulery R; Moukalled N; Ricard L; Stocker N; El-Cheikh J; Mohty M; Bazarbachi A
    Blood Cancer J; 2024 Jan; 14(1):23. PubMed ID: 38272863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
    Lazarus HM; Carreras J; Boudreau C; Loberiza FR; Armitage JO; Bolwell BJ; Freytes CO; Gale RP; Gibson J; Hale GA; Inwards DJ; LeMaistre CF; Maharaj D; Marks DI; Miller AM; Pavlovsky S; Schouten HC; van Besien K; Vose JM; Bitran JD; Khouri IF; McCarthy PL; Yu H; Rowlings P; Serna DS; Horowitz MM; Rizzo JD;
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1323-33. PubMed ID: 19041053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma.
    Aleixo GFP; Wei W; Chen PH; Gandhi NS; Anwer F; Dean R; Hamilton BK; Hill BT; Jagadeesh D; Khouri J; Pohlman B; Sobecks R; Winter A; Caimi P; Majhail NS
    Bone Marrow Transplant; 2023 Dec; 58(12):1384-1389. PubMed ID: 37699993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry.
    Koresawa-Shimizu R; Suzuki R; Uehara Y; Hiramoto N; Sawa M; Fukuda T; Kataoka K; Kanda Y; Oyake T; Kubota Y; Uchida N; Yano S; Kobayashi H; Tanaka J; Atsuta Y; Kondo E
    Bone Marrow Transplant; 2024 Jan; 59(1):125-127. PubMed ID: 37805626
    [No Abstract]   [Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation for the management of follicular lymphoma.
    Hosing C
    Stem Cells Cloning; 2010 May; 3():69-80. PubMed ID: 24198512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role and progress of allogeneic hematopoietic stem cell transplantation in the treatment of refractory/relapsed diffuse large B-cell lymphoma].
    Cao LQ; Mo XD
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):308-312. PubMed ID: 38716606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes.
    Lacoste S; Bhatia S; Chen Y; Bhatia R; O'Connor TR
    PLoS One; 2017; 12(2):e0171473. PubMed ID: 28207808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAR T-cell therapy versus allogeneic HSCT for relapsed or refractory mantle cell lymphoma.
    Iacoboni G; Dietrich S; Liebers N
    Lancet Haematol; 2023 Dec; 10(12):e951-e952. PubMed ID: 38030316
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes of allogeneic hematopoietic cell transplantation after bispecific antibodies in non-Hodgkin lymphomas.
    Peña M; Montané C; Paviglianiti A; Hurtado L; González S; Carro I; Maluquer C; Domingo-Domenech E; Gonzalez-Barca E; Sureda A; Mussetti A
    Bone Marrow Transplant; 2023 Nov; 58(11):1282-1285. PubMed ID: 37626265
    [No Abstract]   [Full Text] [Related]  

  • 17. B-Lymphoblastic Lymphoma in Children: A Case Series From a Single Institution.
    Devine KJ; Trivedi H; Reilly AF
    J Pediatr Hematol Oncol; 2024 Apr; 46(3):e254-e258. PubMed ID: 38408123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The present and future of allogeneic hematopoietic stem cell transplantation for mantle cell lymphoma].
    Liu Y; Huang XJ; Mo XD
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):512-516. PubMed ID: 38715492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mantle cell lymphoma: observation to transplantation.
    Rajabi B; Sweetenham JW
    Ther Adv Hematol; 2015 Feb; 6(1):37-48. PubMed ID: 25642314
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.